Congratulations to Dr. Chandradhish Ghosh, the recipient of the 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship!
The Lectureship was open to any candidate who received their PhD in 2010 or later and has made a significant contribution to medicinal chemistry in their early career. The RSC Medicinal Chemistry Editorial Board selected Dr. Ghosh, from Max Planck Institute of Colloids and Interfaces, Germany, from a short-list of nominees.
Many congratulations to Dr. Ghosh for winning the lectureship.
When he was informed of his selection, Dr. Ghosh said:
“I feel humbled to be recognized by scientists who inspire me. It motivates me to strive harder to solve the problems of human diseases. This would not have been possible without the support of fantastic mentors, colleagues, collaborators, teachers, friends and family.”
About Chandradhish
Dr. Chandradhish Ghosh performed his doctoral studies at Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, under the supervision of Prof. Jayanta Haldar, after first earning his MSc in Chemistry at the University of Delhi. Since 2017, he has been working at the Max Planck Institute for Colloids and Interfaces, in the group of Prof. Peter H. Seeberger. His current work focusses on targeting neglected tropical diseases.
His doctoral work on membrane-active small molecules against drug-resistant pathogens has led to an anti-Ebola drug candidate. He has contributed to the sum of knowledge in the field by the publication of several highly cited reviews. He has won several awards, including the prestigious Gandhian Young Technological Innovation Award in 2015.
To show the range of his scientific work, some of Dr. Ghosh’s recent works are below:
A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics
Med. Chem. Commun., 2017, 8, 516-533
Chem. Commun., 2017, 53, 8427-8430
